cyclohexane has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gabano, E; Gandin, V; Marzano, C; Osella, D; Pelosi, G; Ravera, M | 1 |
Cosgrove, LJ; Good, NM; Head, RJ; Lewanowitsch, T; Lockett, TJ; Ooi, CC; Williams, DB | 1 |
2 other study(ies) available for cyclohexane and Colorectal Neoplasms
Article | Year |
---|---|
trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Crystallography, X-Ray; Cyclohexanes; Diamines; Drug Resistance, Neoplasm; Humans; Isomerism; Molecular Conformation; Organoplatinum Compounds; Oxaliplatin; Platinum; Prodrugs | 2014 |
Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
Topics: Apoptosis; Butyrates; Cell Proliferation; Colorectal Neoplasms; Cyclohexanes; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; HT29 Cells; Humans; L-Lactate Dehydrogenase; Structure-Activity Relationship | 2010 |